The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
# Background Few studies have attempted to assess the effectiveness of formulary management in reducing the antipsychotic costs and utilization across U.S. state Medicaid programs, despite concerns about the potential impact of such formulary management on Medicaid patient health outcomes. # Object...
Saved in:
| Main Authors: | Christian Frois, Thomas O’Connell, Jacqueline Pesa, John Fastenau |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2013-05-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9853 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
by: Amanda M. Farr, et al.
Published: (2014-10-01) -
Open Access to Antipsychotics in State Medicaid Programs: Effect on Healthcare Resource Utilization and Costs among Patients with Serious Mental Illness
by: Rashmi Patel, et al.
Published: (2025-06-01) -
Association Between Fixed-Dose Combination Use and Medication Adherence, Health Care Utilization, and Costs Among Medicaid Beneficiaries
by: Donglan Zhang, PhD, et al.
Published: (2025-09-01) -
Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C
by: Xiaohan Ying, et al.
Published: (2025-01-01) -
Evaluation of drug interactions in outpatients taking antipsychotic medications
by: Bshra A. Alsfouk, et al.
Published: (2025-05-01)